PRESS RELEASE: "ZOLL ANNOUNCES ACQUISITION OF KYMA MEDICAL
ZOLL® Medical Corporation, an Asahi Kasei Group company that manufactures medical devices and related software solutions, today announced that it has acquired Tel Aviv, Israel-based Kyma Medical Technologies, Ltd., which develops technologies to measure early signs of congestive heart failure.
Access Press Release
KYMA TO PRESENT AT ATA 2015: THE 20TH ANNUAL TELEMEDICINE
MEETING AND TRADE SHOW, MONDAY MAY 4, 2015
Kyma is pleased to have been selected to present at the 2015 ATA Meeting And Trade Show. The presentation, titled: "Noninvasive Lung Water Determination Using Novel Radiofrequency Technology: Clinical Validation," will take place on Monday, May 4, 2015, at 4:15 PM, at the LA Convention Center.
KYMA ANNOUNCES CE MARK FOR ITS NEXT GENERATION µCOR SYSTEM
The next-generation µCor System expands upon the previous platform to monitor a patient’s thoracic fluid content along with other important vital signs in different clinical and home environments. CE Mark of the next generation device marks a milestone in the company’s development plan and enables the company to pursue new business opportunities.
RESULTS FROM ANIMAL STUDY PUBLISHED IN THE JOURNAL "CRITICAL CARE"
Results from an animal study comparing Kyma RF Fluid Index (RFFI) and invasive extra-vascular lung water measurement published in Crit Care. 2014; 18(Suppl 1): P137.
KYMA ANNOUNCED AS SECOND PLACE WINNER OF THE 2014 TCT
INNOVATIVE CARDIOVASCULAR TECHNOLOGIES AWARD
After being selected to give an oral presentation at the prestigious annual TCT event, Kyma was announced yesterday as the second place winner of the 2014 Innovative Cardiovascular Technologies Award.
KYMA TO PRESENT AT THE TCT INNOVATION SESSION,
SUNDAY, SEPTEMBER 14, 2014
Kyma is pleased to present at the 2014 TCT Innovation Session. The presentation, titled: " A Novel Modality for Monitoring Tissue Hydration in Congestive Heart Failure Patients: Technology Overview and FIH Results" will take place on Sunday, September 14, Washington DC, at 2:55 PM.Click here to access the full agenda on the TCT website
KYMA TO PRESENT AT THE 23RD ICISA
Kyma accepted to give an oral poster presentation at the 23rd International Congress of the Israel Society of Anesthesiologists and critical care (ICISA 2014) taking place September 16-18, 2014 in Tel-Aviv, Israel.
KYMA TO PRESENT AT THE HFSA 2014 SCIENTIFIC MEETING
KYMA accepted to present two posters at the HFSA Annual Scientific Meeting taking place September 14-17, 2014 in Las Vegas, Nevada.
KYMA TO PRESENT THREE ABSTRACTS AT HEART
FAILURE 2014 CONGRESS
Kyma will present three posters at the ESC Heart Failure congress held in Athens, Greece, 17-20 May 2014.
KYMA TO PRESENT A POSTER AT THE 34TH ISICEM, MARCH 18-21, 2014,
The poster - "Novel technology for Non-Invasive Thoracic Fluid Measurement – an Animal Model Comparative Study", will be presented at the 34th International Symposium on Intensive Care and Emergency Medicine taking place March 18-21, 2014 in Brussels, Belgium.
KYMA OPENS A SUBSIDIARY IN THE UNITED STATES
Kyma has opened a subsidiary in the US that will support the company's activities in the US market over the coming years. The company has recently initiated clinical activity in leading centers in the US as preparation for market launch.
KYMA LAUNCHED CLINICAL TRIAL AT THE MAYO CLINIC
Kyma has launched a clinical trial at the Mayo Clinic. The trial will recruit up to 60 patients over a two-year period, and is designed to test the usability of the Kyma µ-Cor and establish its efficacy in predicting lung fluid congestion.